Biopsy Devices Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis
Buy NowBiopsy Devices Market Outlook
Biopsy Devices Market is anticipated to attain US$ 3.84 Billion by 2030, according to Renub Research. Biopsy devices preserve a pivotal role in healthcare by facilitating the extraction of tissue samples for diagnostic purposes. They are instrumental in identifying numerous illnesses, such as cancer, infections, and autoimmune issues. Technological improvements have increased the precision and reduced invasiveness of biopsy gadgets, leading to decreased patient pain and faster recuperation times. From traditional needle biopsies to advanced imaging-guided techniques, those gadgets empower healthcare specialists to make precise diagnoses and customize treatment plans for stepped forward patient results.
Biopsy Devices Market is predicted to increase at a CAGR of 6.94% during 2024 to 2030
The escalating international cancer burden is the primary catalyst propelling the growth of the biopsy devices market. With an estimated 1.9 million new cancer instances projected in the U.S. for 2022, as mentioned by the American Cancer Society, the urgency to enhance diagnostic abilities becomes obvious. This surge in cancer occurrence stimulates the innovation and refinement of biopsy techniques, driving the demand for more efficient, more secure, and technologically superior biopsy devices to facilitate timely and correct diagnoses, ultimately improving patient consequences.
Moreover, the growing worldwide elderly population correlates with a heightened occurrence of diseases, including cancer, driving the want for biopsy devices to permit early detection and disorder tracking. Further, the surge in chronic sicknesses necessitates regular biopsies for specific diagnosis and remedy techniques, further amplifying the demand for these devices. This dual trend underscores the critical role of biopsy devices in cutting-edge healthcare, prompting global biopsy device market growth to cater to the growing diagnostic desires of healthcare professionals and ensure improved patient care results.
Innovations power the global biopsy device market to increase, improving efficacy, speed, and protection. Vacuum-assisted biopsy devices enable faster, more comfortable tissue extraction, enhancing the patient's experience. Real-time imaging integration like ultrasound, CT scans, or MRI complements accuracy, decreasing complications. These innovations boost product adoption, fueling the market enlargement of biopsy devices. Rising healthcare infrastructure investments modernize centers, particularly in rising economies, ensuring broader diagnostic access. Globally prioritizing accurate diagnostics, advanced biopsy devices grow to be fundamental, increasing the biopsy devices market and improving patient care. Hence, the Biopsy Devices Market was worth US$ 2.40 Billion in 2023.
Asia Pacific presents substantial growth prospects, driven by advancing healthcare infrastructure, increasing cancer incidence, and unmet patient needs. Point-of-care biopsy devices revolutionize diagnostics, offering rapid on-site assessments, which are especially beneficial in resource-limited or urgent medical scenarios. These devices provide real-time results, reducing reliance on extensive lab infrastructure and enhancing patient care in emergencies or remote settings. Both liquid biopsy and point-of-care devices meet the demand for efficient diagnostics, fostering positive momentum in the global biopsy devices market.
Biopsy needles play a critical role in the biopsy devices market
By product, the biopsy devices market is fragmented into Needle-Based Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps, and Others. Biopsy needles are among the crucial products in the global biopsy device market. This is due to their vital role in tissue sample extraction for diagnostic purposes. These needles enable minimally invasive techniques, lowering patient discomfort and restoration time. With the increasing incidence of diseases, which includes cancer, the need for correct and well-timed analysis is growing, propelling the want for biopsy devices. Biopsy needles provide precision and reliability, permitting healthcare experts to gain high-quality tissue samples for histological examination, guiding remedy choices, and improving patient outcomes.
Breast biopsy has a notable portion of the global biopsy devices market
By application, the biopsy devices market is segmented into Breast Biopsy, Lung Biopsy, Prostate Biopsy, Liver Biopsy, Gastroenterology Biopsy, and Others. Breast biopsy holds one of the most significant shares in the biopsy devices market. This is due to its significance in breast cancer diagnosis. According to breastcancer.org, in 2023, a predicted 297,790 new instances of invasive breast cancers are expected to be diagnosed in U.S. women. With breast cancer being one of the most common conventional cancers globally, the demand for correct and minimally invasive diagnostic techniques is high. Breast biopsy devices enable the extraction of tissue samples from suspicious breast lesions, facilitating early detection and treatment planning. Moreover, improvements in breast biopsy technologies, such as vacuum-assisted and stereotactic biopsies, enhance diagnostic accuracy and patient consolation, similarly driving biopsy devices market dominance.
CT scan technology ranks among the most extensively employed global biopsy devices
By technology, the biopsy devices market is categorized into CT Scan, Stereotactic, Ultrasound, MRI, and Others. CT scan technology is among the widely utilized technologies in the global biopsy devices market. This is because of its precision and versatility. CT-guided biopsies provide real-time imaging guidance, permitting healthcare experts to accurately target and extract tissue samples from particular areas of the subject. This technology enhances diagnostic accuracy, in particular in deep-seated or complex lesions. Also, CT scans offer specified anatomical facts, aiding remedy planning and tracking. With their excellent availability and effectiveness, CT-guided biopsies remain a cornerstone in the biopsy device market.
Hospitals are likely to hold a substantial portion of the biopsy devices market
The biopsy devices market is classified into Hospitals, Diagnostic & Imaging Centers, and Others by end-user. Hospitals may command an extensive share of the biopsy devices market. This is due to their function as primary healthcare companies and centers for diagnostic approaches. Hospitals frequently have specialized departments prepared with superior imaging technologies and skilled healthcare professionals capable of acting biopsies. Further, hospitals manage a vast range of scientific conditions, growing the need for biopsy devices across diverse specialties and departments.
United States maintained a prominent position in the global biopsy devices market
By country, the biopsy devices market is split into North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, the Netherlands, and Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, and New Zealand), Latin America (Brazil, Mexico, and Argentina), Middle East & Africa (South Africa, Saudi Arabia, and the United Arab Emirates). The United States held a leading share of the global biopsy devices market. This is due to established market participants domiciled in the area. This trend is expected to persist, with the United States keeping a considerable market proportion. High adoption rates of developed devices like vacuum-assisted biopsy systems and increasing demand for disposable devices support the regional market. Further, the U.S. conducts the highest range of biopsies, facilitated by a reasonably stringent FDA approval procedure for scientific devices. Government projects advocating for regular cancer screening increase the biopsy devices market in the location.
Key Players
Cardinal Health, Inc., Hologic, Inc., Danaher Corporation, Becton, Dickinson and Company, Boston Scientific Corporation, Medtronic plc., Olympus Corporation, and CONMED Corporation are the prominent companies in the biopsy devices market.
- In August 2022 - TransMed7, LLC announced the inaugural "First in Human" clinical case using the commercial production version of the Heron XPS device, part of the innovative Heron family of vacuum-assisted, single insertion/multiple collection soft tissue biopsy devices.
- In September 2023 - Boston Scientific Corporation received FDA approval for the latest-generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) Device, enhancing procedural performance and safety. The device, aimed at reducing stroke risk in non-valvular atrial fibrillation (NVAF) patients who require an alternative to oral anticoagulation therapy, now boasts a polymer coating, visualization markers, and a broader size matrix to accommodate a wider patient population.
Product – Market breakup in 5 viewpoints:
1. Needle-Based Guns
2. Biopsy Guidance Systems
3. Biopsy Needles
4. Biopsy Forceps
5. Others
Application – Market breakup in 6 viewpoints:
1. Breast Biopsy
2. Lung Biopsy
3. Prostate Biopsy
4. Liver Biopsy
5. Gastroenterology Biopsy
6. Others
Technology – Market breakup in 5 viewpoints:
1. CT Scan
2. Stereotactic Guided
3. Ultrasound Guided
4. MRI Guided
5. Others
End-User – Market breakup in 3 viewpoints:
1. Hospitals
2. Diagnostic & Imaging Center
3. Others
Country – Market of 25 Countries Covered in the Report:
1. North America
1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherland
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
• Overview
• Recent Development
• Revenue Analysis
Company Analysis:
1. Cardinal Health, Inc.
2. Hologic, Inc.
3. Danaher Corporation
4. Becton, Dickinson and Company
5. Boston Scientific Corporation
6. Medtronic plc.
7. Olympus Corporation
8. CONMED Corporation
Report Details:
| Report Features | Details |
| Base Year | 2023 |
| Historical Period | 2019 – 2023 |
| Forecast Period | 2024 – 2030 |
| Market | US$ Billion |
| Segment Covered | Product, Application, Technology, End User, and Countries |
| Countries Covered | United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, Brazil, Mexico, Argentina,Saudi Arabia, United Arab Emirates, and South Africa |
| Companies Covered | Cardinal Health, Inc., Hologic, Inc., Danaher Corporation, Becton, Dickinson and Company, Boston Scientific Corporation, Medtronic plc., Olympus Corporation, and CONMED Corporation |
| Customization Scope | 20% Free Customization |
| Post-Sale Analyst Support | 1 Year (52 Weeks) |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Biopsy Devices Market
6. Market Share – Global Biopsy Devices
6.1 By Product
6.2 By Application
6.3 By Technology
6.4 By End User
6.5 By Countries
7. Product – Biopsy Devices Market
7.1 Needle-Based Guns
7.2 Biopsy Guidance Systems
7.3 Biopsy Needles
7.4 Biopsy Forceps
7.5 Others
8. Application – Biopsy Devices Market
8.1 Breast Biopsy
8.2 Lung Biopsy
8.3 Prostate Biospy
8.4 Liver Biopsy
8.5 Gastroenterology Biopsy
8.6 Others
9. Technology – Biopsy Devices Market
9.1 CT Scan
9.2 Stereotactic Guided
9.3 Ultrasound Guided
9.4 MRI Guided
9.5 Others
10. End User – Biopsy Devices Market
10.1 Hospitals
10.2 Diagnostic & Imaging Center
10.3 Others
11. Countries – Biopsy Devices Market
11.1 North America
11.1.1 United States
11.1.2 Canada
11.2 Europe
11.2.1 France
11.2.2 Germany
11.2.3 Italy
11.2.4 Spain
11.2.5 United Kingdom
11.2.6 Belgium
11.2.7 Netherland
11.2.8 Turkey
11.3 Asia Pacific
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 South Korea
11.3.5 Thailand
11.3.6 Malaysia
11.3.7 Indonesia
11.3.8 Australia
11.3.9 New Zealand
11.4 Latin America
11.4.1 Brazil
11.4.2 Mexico
11.4.3 Argentina
11.5 Middle East & Africa
11.5.1 Saudi Arabia
11.5.2 UAE
11.5.3 South Africa
12. Porter’s Five Forces Analysis – Biopsy Devices Market
12.1 Bargaining Power of Buyers
12.2 Bargaining Power of Suppliers
12.3 Degree of Rivalry
12.4 Threat of New Entrants
12.5 Threat of Substitutes
13. SWOT Analysis – Biopsy Devices Market
13.1 Strength
13.2 Weakness
13.3 Opportunity
13.4 Threat
14. Key Players Analysis
14.1 Cardinal Health, Inc.
14.1.1 Overview
14.1.2 Recent Development
14.1.3 Revenue Analysis
14.2 Hologic, Inc.
14.2.1 Overview
14.2.2 Recent Development
14.2.3 Revenue Analysis
14.3 Danaher Corporation
14.3.1 Overview
14.3.2 Recent Development
14.3.3 Revenue Analysis
14.4 Becton, Dickinson and Company
14.4.1 Overview
14.4.2 Recent Development
14.4.3 Revenue Analysis
14.5 Boston Scientific Corporation
14.5.1 Overview
14.5.2 Recent Development
14.5.3 Revenue Analysis
14.6 Medtronic plc.
14.6.1 Overview
14.6.2 Recent Development
14.6.3 Revenue Analysis
14.7 Olympus Corporation
14.7.1 Overview
14.7.2 Recent Development
14.7.3 Revenue Analysis
14.8 CONMED Corporation
14.8.1 Overview
14.8.2 Recent Development
14.8.3 Revenue Analysis
List of Figures:
Figure-01: Global – Biopsy Devices Market (Billion US$), 2019 – 2023
Figure-02: Global – Forecast for Biopsy Devices Market (Billion US$), 2024 – 2030
Figure-03: Product – Needle-Based Guns Market (Million US$), 2019 – 2023
Figure-04: Product – Forecast for Needle-Based Guns Market (Million US$), 2024 – 2030
Figure-05: Product – Biopsy Guidance Systems Market (Million US$), 2019 – 2023
Figure-06: Product – Forecast for Biopsy Guidance Systems Market (Million US$), 2024 – 2030
Figure-07: Product – Biopsy Needles Market (Million US$), 2019 – 2023
Figure-08: Product – Forecast for Biopsy Needles Market (Million US$), 2024 – 2030
Figure-09: Product – Biopsy Forceps Market (Million US$), 2019 – 2023
Figure-10: Product – Forecast for Biopsy Forceps Market (Million US$), 2024 – 2030
Figure-11: Product – Others Market (Million US$), 2019 – 2023
Figure-12: Product – Forecast for Others Market (Million US$), 2024 – 2030
Figure-13: Application – Breast Biopsy Market (Million US$), 2019 – 2023
Figure-14: Application – Forecast for Breast Biopsy Market (Million US$), 2024 – 2030
Figure-15: Application – Lung Biopsy Market (Million US$), 2019 – 2023
Figure-16: Application – Forecast for Lung Biopsy Market (Million US$), 2024 – 2030
Figure-17: Application – Prostate Biospy Market (Million US$), 2019 – 2023
Figure-18: Application – Forecast for Prostate Biospy Market (Million US$), 2024 – 2030
Figure-19: Application – Liver Biopsy Market (Million US$), 2019 – 2023
Figure-20: Application – Forecast for Liver Biopsy Market (Million US$), 2024 – 2030
Figure-21: Application – Gastroenterology Biopsy Market (Million US$), 2019 – 2023
Figure-22: Application – Forecast for Gastroenterology Biopsy Market (Million US$), 2024 – 2030
Figure-23: Application – Others Market (Million US$), 2019 – 2023
Figure-24: Application – Forecast for Others Market (Million US$), 2024 – 2030
Figure-25: Technology – CT Scan Market (Million US$), 2019 – 2023
Figure-26: Technology – Forecast for CT Scan Market (Million US$), 2024 – 2030
Figure-27: Technology – Stereotactic Guided Market (Million US$), 2019 – 2023
Figure-28: Technology – Forecast for Stereotactic Guided Market (Million US$), 2024 – 2030
Figure-29: Technology – Ultrasound Guided Market (Million US$), 2019 – 2023
Figure-30: Technology – Forecast for Ultrasound Guided Market (Million US$), 2024 – 2030
Figure-31: Technology – MRI Guided Market (Million US$), 2019 – 2023
Figure-32: Technology – Forecast for MRI Guided Market (Million US$), 2024 – 2030
Figure-33: Technology – Others Market (Million US$), 2019 – 2023
Figure-34: Technology – Forecast for Others Market (Million US$), 2024 – 2030
Figure-35: End User – Hospitals Market (Million US$), 2019 – 2023
Figure-36: End User – Forecast for Hospitals Market (Million US$), 2024 – 2030
Figure-37: End User – Diagnostic & Imaging Center Market (Million US$), 2019 – 2023
Figure-38: End User – Forecast for Diagnostic & Imaging Center Market (Million US$), 2024 – 2030
Figure-39: End User – Others Market (Million US$), 2019 – 2023
Figure-40: End User – Forecast for Others Market (Million US$), 2024 – 2030
Figure-41: United States – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-42: United States – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-43: Canada – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-44: Canada – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-45: France – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-46: France – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-47: Germany – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-48: Germany – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-49: Italy – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-50: Italy – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-51: Spain – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-52: Spain – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-53: United Kingdom – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-54: United Kingdom – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-55: Belgium – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-56: Belgium – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-57: Netherland – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-58: Netherland – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-59: Turkey – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-60: Turkey – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-61: China – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-62: China – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-63: Japan – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-64: Japan – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-65: India – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-66: India – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-67: South Korea – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-68: South Korea – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-69: Thailand – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-70: Thailand – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-71: Malaysia – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-72: Malaysia – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-73: Indonesia – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-74: Indonesia – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-75: Australia – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-76: Australia – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-77: New Zealand – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-78: New Zealand – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-79: Brazil – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-80: Brazil – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-81: Mexico – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-82: Mexico – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-83: Argentina – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-84: Argentina – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-85: Saudi Arabia – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-86: Saudi Arabia – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-87: UAE – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-88: UAE – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-89: South Africa – Biopsy Devices Market (Million US$), 2019 – 2023
Figure-90: South Africa – Forecast for Biopsy Devices Market (Million US$), 2024 – 2030
Figure-91: Cardinal Health, Inc. – Global Revenue (Million US$), 2019 – 2023
Figure-92: Cardinal Health, Inc. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-93: Hologic, Inc. – Global Revenue (Million US$), 2019 – 2023
Figure-94: Hologic, Inc. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-95: Danaher Corporation – Global Revenue (Million US$), 2019 – 2023
Figure-96: Danaher Corporation – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-97: Becton, Dickinson and Company – Global Revenue (Million US$), 2019 – 2023
Figure-98: Becton, Dickinson and Company – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-99: Boston Scientific Corporation – Global Revenue (Million US$), 2019 – 2023
Figure-100: Boston Scientific Corporation – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-101: Medtronic plc. – Global Revenue (Million US$), 2019 – 2023
Figure-102: Medtronic plc. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-103: Olympus Corporation – Global Revenue (Million US$), 2019 – 2023
Figure-104: Olympus Corporation – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-105: CONMED Corporation – Global Revenue (Million US$), 2019 – 2023
Figure-106: CONMED Corporation – Forecast for Global Revenue (Million US$), 2024 – 2030
List of Tables:
Table-01: Global – Biopsy Devices Market Share by Product (Percent), 2019 – 2023
Table-02: Global – Forecast for Biopsy Devices Market Share by Product (Percent), 2024 – 2030
Table-03: Global – Biopsy Devices Market Share by Application (Percent), 2019 – 2023
Table-04: Global – Forecast for Biopsy Devices Market Share by Application (Percent), 2024 – 2030
Table-05: Global – Biopsy Devices Market Share by Technology (Percent), 2019 – 2023
Table-06: Global – Forecast for Biopsy Devices Market Share by Technology (Percent), 2024 – 2030
Table-07: Global – Biopsy Devices Market Share by End User (Percent), 2019 – 2023
Table-08: Global – Forecast for Biopsy Devices Market Share by End User (Percent), 2024 – 2030
Table-09: Global – Biopsy Devices Market Share by Countries (Percent), 2019 – 2023
Table-10: Global – Forecast for Biopsy Devices Market Share by Countries (Percent), 2024 – 2030
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com